SINOPHARM GROUP 1/5/O.N. (X2S1) — Cash Flow Quality Index
SINOPHARM GROUP 1/5/O.N. (X2S1) has a Cash Flow Quality Index of 1.98x as of December 2025. Operating cash flow of €14.14 Billion exceeds net income of €7.16 Billion, indicating high earnings quality where cash backs reported profits. Also explore SINOPHARM GROUP 1/5/O.N. balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SINOPHARM GROUP 1/5/O.N. Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for SINOPHARM GROUP 1/5/O.N. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SINOPHARM GROUP 1/5/O.N. (X2S1) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for SINOPHARM GROUP 1/5/O.N. (2021–2025)
Year-by-year earnings quality comparison for SINOPHARM GROUP 1/5/O.N.. For live market cap and the full company financial profile, see X2S1 company net worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.98x | €14.14 Billion | €7.16 Billion | ▲ +20.6% |
| 2024 | 1.64x | €11.55 Billion | €7.05 Billion | ▼ -13.7% |
| 2023 | 1.90x | €17.17 Billion | €9.05 Billion | ▼ -22.9% |
| 2022 | 2.46x | €20.96 Billion | €8.53 Billion | ▲ +105.0% |
| 2021 | 1.20x | €9.31 Billion | €7.76 Billion | — |